Caristo: Caristo Diagnostics' CaRiPlaque technology, an AIassisted image analysis application to aid the diagnosis of CAD receives US FDA 510(k) clearance

Caristo Diagnostics, on a mission to transform the diagnosis and treatment of cardiovascular disease, announced it has received US Food and Drug Administration (FDA) 510(k) clearance of its CaRi─Plaque technology, an